1-(N-benzoyl-glycyl)-piperidine | 51769-86-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(N-benzoyl-glycyl)-piperidine
• 英文别名: N-[2-oxo-2-(piperidin-1-yl)ethyl]benzamide；N-(piperidinylcarbonylmethyl)benzamide；Hippursaeure-(piperidid)；N-(2-oxo-2-piperidin-1-ylethyl)benzamide
• CAS: 51769-86-9
• 化学式: C₁₄H₁₈N₂O₂
• mdl: MFCD00711372
• 分子量: 246.309
• InChiKey: CIUSCOSXRVWQDO-UHFFFAOYSA-N

物化性质

• 熔点：
  91 °C
• 沸点：
  501.8±33.0 °C(Predicted)
• 密度：
  1.153±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.428
• 拓扑面积：
  49.4
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-(N-benzoyl-glycyl)-piperidine 在 劳森试剂 作用下， 以 xylene 为溶剂， 反应 0.08h， 以78%的产率得到2-phenyl-5-piperidinothiazole
  参考文献：
  名称：

  从双功能底物制备取代的噻吩、噻唑和 1,3,4-噻二唑-2(3H)-噻吩的新方法和简便方法

  摘要：

  LR（Lawesson 试剂）与 4-氧代羧酸衍生物 I、N-酰基氨基酸衍生物 III 和 N-酰基-N'-乙氧基羰基肼 V 的反应顺利产生取代的噻吩 II、噻唑 IV 和 1,3,4-噻二唑-2(3H)-硫酮 VI.

  DOI：

  10.1246/cl.1983.809
• 作为产物：
  描述：

  苯甲酰氯 在 硫酸 、 sodium hydroxide 作用下， 以 甲醇 为溶剂， 反应 7.0h， 生成 1-(N-benzoyl-glycyl)-piperidine
  参考文献：
  名称：

  Synthesis, biological activity screening and molecular modeling study of acylaminoacetamide derivatives

  摘要：

  In this study, non-rigid analogs of thalidomide have been designed in order to develop potentially active, more effective and safer lead molecules for disorders caused or contributed by inflammation. Five different series of acylaminoacetamide compounds were synthesized, and the biological inhibitory potency of the title compounds has been determined by evaluating their effects on COX-2 isoenzyme expression and PGE(2) production in A549 (human lung adenocarcinoma) cell lines. Among the studied series, N-[2-(isopropylamino)-2-oxoethyl]isonicotinamide is the most active inhibitory compound on COX-2 isoenzyme expression, and N-[2-oxo-2-(pyrolydine-1-yl)etyl]isonicotinamide is the most active inhibitory compound on the biosynthesis of PGE(2). Molecular docking studies and molecular dynamics simulations were also applied to investigate non-covalent interactions of the most active compounds inside the active side of the crystal structure of murine cyclooxygenase 2 (mCOX-2) isoenzyme.

  DOI：

  10.1007/s00044-015-1419-4

文献信息

• Metal-Organic Framework Based on Copper and Carboxylate-Imidazole as Robust and Effective Catalyst in the Oxidative Amidation of Carboxylic Acids and Formamides
  作者：María Albert-Soriano、Isidro M. Pastor

  DOI：10.1002/ejoc.201600991

  日期：2016.10

  The Spanish Ministerio de Economia y Competitividad (CTQ2015-66624-P) and the University of Alicante.

  西班牙经济与竞争部长 (CTQ2015-66624-P) 和阿利坎特大学。
• Pyrazole compounds and their use as antidiabetes agents
  申请人：Takagi Masaki

  公开号：US20070032529A1

  公开（公告）日：2007-02-08

  The present invention provides a pyrazole compound that has liver glycogen phosphorylase inhibitory activity and is useful as a therapeutic or prophylactic agent for diabetes, the pyrazole compound represented by the following general formula (I): wherein Ring Q represents an aryl or heteroaromatic group, R 1 represents a hydrogen atom, a halogen atom, a C 1-6 alkyl group or a C 1-6 alkoxy group, R 2 represents a halogen atom, a C 1-6 alkyl group, a C 1-6 alkoxy group or an azido group, R 3 represents a halogen atom, a hydroxyl group, a C 1-6 alkyl group, a halo C 1-6 alkyl group, a C 1-6 alkoxy group, an azido group, an amino group, an acylamino group or a C 1-6 alkylsulfonylamino group, R 4 and R 5 are identical with or different from each other and represent a hydrogen atom, a substituted or unsubstituted C 1-6 alkyl group, a C 3-8 cycloalkyl group, a substituted or unsubstituted saturated heterocyclic group, a substituted or unsubstituted aryl group, a C 7-14 aralkyl group, a heteroaromatic group, or the like, or a pharmacologically acceptable salt thereof.

  本发明提供了一种具有肝糖原磷酸化酶抑制活性的吡唑化合物，用作糖尿病的治疗或预防剂，所述吡唑化合物由以下通用式（I）表示：其中环Q代表芳基或杂芳基，R1代表氢原子、卤原子、C1-6烷基或C1-6烷氧基，R2代表卤原子、C1-6烷基、C1-6烷氧基或偶氮基，R3代表卤原子、羟基、C1-6烷基、卤代C1-6烷基、C1-6烷氧基、偶氮基、氨基、酰胺基或C1-6烷基磺酰胺基，R4和R5彼此相同或不同，代表氢原子、取代或未取代的C1-6烷基、取代或未取代的C3-8环烷基、取代或未取代的饱和杂环基、取代或未取代的芳基、C7-14芳基烷基、杂芳基等，或其药理学上可接受的盐。
• [EN] LYSINE-SPECIFIC HISTONE DEMETHYLASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS<br/>[FR] INHIBITEURS DE L'HISTONE DÉMÉTHYLASE SPÉCIFIQUE DE LA LYSINE POUR LE TRAITEMENT DE NÉOPLASMES MYÉLOPROLIFÉRATIFS
  申请人：IMAGO BIOSCIENCES INC

  公开号：WO2021118996A1

  公开（公告）日：2021-06-17

  Disclosed herein are methods for treating or preventing myeloproliferative neoplasms in a subject in need thereof, and for effecting specific clinically relevant endpoints, comprising administering a therapeutically effective amount of an LSD1 inhibitor.

  本文公开了用于治疗或预防需要的对象中的骨髓增生性肿瘤，并实现特定临床相关终点的方法，包括给予治疗有效量的LSD1抑制剂。
• [EN] LYSINE-SPECIFIC HISTONE DEMETHYLASE AS A NOVEL THERAPEUTIC TARGET IN MYELOPROLIFERATIVE NEOPLASMS<br/>[FR] HISTONE DÉMÉTHYLASE SPÉCIFIQUE DE LA LYSINE EN TANT QUE NOUVELLE CIBLE THÉRAPEUTIQUE DANS DES NÉOPLASMES MYÉLOPROLIFÉRATIFS
  申请人：IMAGO BIOSCIENCES INC

  公开号：WO2017079753A1

  公开（公告）日：2017-05-11

  Disclosed herein are methods for treating or preventing myeloproliferative neoplasms in a subject in need thereof, and for effecting specific clinically relevant endpoints, comprising administering a therapeutically effective amount of an LSDl inhibitor.

  本文揭示了一种治疗或预防需要的患者中的骨髓增生性肿瘤的方法，并实现特定的临床相关终点，包括给予治疗有效量的LSD1抑制剂。
• NEW BENZAMIDE DERIVATIVES AS BRADYKININ ANTAGONISTS
  申请人：Vago Istvan

  公开号：US20100087423A1

  公开（公告）日：2010-04-08

  The present invention relates to new phenylsulfamoyl benzamide derivatives of formula (I) wherein R 1 -R 5 and Z are as defined in the claims, and optical antipodes or racemates and/or salts and/or hydrates and/or solvates thereof, which are selective antagonists of bradykinin B1, to processes for producing these compounds, to pharmacological compositions containing them and to their use in therapy or prevention of painful and inflammatory conditions.

  本发明涉及新的苯磺酰苯酰胺衍生物，其化学式为(I)，其中R1-R5和Z如权利要求中所定义，以及其光学对映体或外消旋体和/或盐和/或水合物和/或溶剂合物，它们是缓激肽B1选择性拮抗剂，用于制备这些化合物的过程，包含它们的药理学组合物以及在治疗或预防疼痛和炎症症状中的应用。